127 related items for PubMed ID: 11207085
1. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjekshus J, Simonsen S, Gullestad L.
Eur Heart J; 2001 Mar; 22(5):428-36. PubMed ID: 11207085
[Abstract] [Full Text] [Related]
2. Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation.
Ventura HO, Milani RV, Lavie CJ, Smart FW, Stapleton DD, Toups TS, Price HL.
Circulation; 1993 Nov; 88(5 Pt 2):II281-5. PubMed ID: 8222166
[Abstract] [Full Text] [Related]
3. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR.
Transplantation; 1995 Feb 15; 59(3):352-6. PubMed ID: 7871564
[Abstract] [Full Text] [Related]
4. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.
Transpl Int; 2003 May 15; 16(5):313-20. PubMed ID: 12759722
[Abstract] [Full Text] [Related]
5. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
Russo C, Olivieri O, Girelli D, Azzini M, Stanzial AM, Guarini P, Friso S, De Franceschi L, Corrocher R.
J Hypertens; 1995 Dec 15; 13(12 Pt 2):1823-6. PubMed ID: 8903660
[Abstract] [Full Text] [Related]
6. Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients.
Andreassen AK, Hartmann A, Offstad J, Geiran O, Kvernebo K, Simonsen S.
J Am Coll Cardiol; 1997 May 15; 29(6):1324-31. PubMed ID: 9137231
[Abstract] [Full Text] [Related]
7. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK, Abbey M, Nestel PJ, Howe PR.
J Hypertens; 1994 Sep 15; 12(9):1041-5. PubMed ID: 7852747
[Abstract] [Full Text] [Related]
8. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
Arch Neurol; 2006 Oct 15; 63(10):1402-8. PubMed ID: 17030655
[Abstract] [Full Text] [Related]
9. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
Barenbrock M, Colmorgen U, Firschka E, Gellert J, Lippert J, Schröder K, Spieker C, Voigt-Ladner G, Wagner K, Neumayer HH.
Clin Nephrol; 1995 Jun 15; 43(6):388-91. PubMed ID: 7554523
[Abstract] [Full Text] [Related]
10. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y.
Nephrol Dial Transplant; 2005 Aug 15; 20(8):1714-20. PubMed ID: 15919696
[Abstract] [Full Text] [Related]
11. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
Busnach G, Stragliotto E, Minetti E, Perego A, Brando B, Broggi ML, Civati G.
J Nephrol; 1998 Aug 15; 11(2):87-93. PubMed ID: 9589380
[Abstract] [Full Text] [Related]
12. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 15; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
13. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant.
Leenen FH, Coletta E, Davies RA.
Am J Cardiol; 2007 Aug 01; 100(3):531-5. PubMed ID: 17659942
[Abstract] [Full Text] [Related]
14. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
Nephrol Dial Transplant; 2008 Feb 01; 23(2):573-9. PubMed ID: 17984104
[Abstract] [Full Text] [Related]
15. Fish oil as an adjuvant in the treatment of hypertension.
Gray DR, Gozzip CG, Eastham JH, Kashyap ML.
Pharmacotherapy; 1996 Feb 01; 16(2):295-300. PubMed ID: 8820475
[Abstract] [Full Text] [Related]
16. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
J Hum Hypertens; 2004 Mar 01; 18(3):215-22. PubMed ID: 14973517
[Abstract] [Full Text] [Related]
17. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
Arch Mal Coeur Vaiss; 2001 Aug 01; 94(8):907-12. PubMed ID: 11575229
[Abstract] [Full Text] [Related]
18. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Cicero AF, Derosa G, Di Gregori V, Bove M, Gaddi AV, Borghi C.
Clin Exp Hypertens; 2010 Jan 01; 32(2):137-44. PubMed ID: 20374188
[Abstract] [Full Text] [Related]
19. Long-term effects of cyclosporine on renal function in organ transplant recipients.
Bantle JP, Paller MS, Boudreau RJ, Olivari MT, Ferris TF.
J Lab Clin Med; 1990 Feb 01; 115(2):233-40. PubMed ID: 2405085
[Abstract] [Full Text] [Related]
20. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
O'Keefe JH, Abuissa H, Sastre A, Steinhaus DM, Harris WS.
Am J Cardiol; 2006 Apr 15; 97(8):1127-30. PubMed ID: 16616012
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
